Target intelligence / Profile preview

Envelope glycoprotein trimer of HIV-1 (HIV-1 Env trimer)

Target
HIV-1 Env trimer
Molecular classification
Viral fusion protein, Class I viral fusion protein, Other (virus-encoded glycoprotein complex)
01

Overview

The **Envelope glycoprotein trimer of HIV-1** (commonly called "HIV-1 Env trimer") is a membrane-anchored homotrimeric complex composed of three gp120 and three gp41 subunits, derived from cleavage of the gp160 precursor[4][5][3]. Located on the surface of HIV-1 virions, the Env trimer mediates viral entry by first binding to the CD4 receptor and a co-receptor (CCR5 or CXCR4) on host cells, triggering conformational changes that drive the gp41-mediated fusion of the viral and host membranes[1][2][3][5]. Env is the only HIV-1 structure exposed to the host immune system and is the main target for neutralizing antibodies; its extreme sequence variability, extensive glycosylation, and conformational flexibility help the virus evade immune responses[3][6]. Because of these properties, the Env trimer is a major focus for vaccine and therapeutic development, as well as basic research into viral entry and immune evasion mechanisms[3][6][1].

Other names
HIV-1 Env trimerHIV-1 envelope glycoproteingp160 trimergp120-gp41 trimerHIV-1 envelope spike
02

Mechanism of action

Inhibition of viral membrane fusion; Blockade of CD4 or co-receptor binding

03

Biological functions

Viral entry/fusionReceptor recognitionImmune evasion
04

Disease associations

Infection (specifically, HIV/AIDS)
05

Safety considerations

High sequence variability and glycosylation impeding vaccine/drug developmentPotential for immune escapeAntibody-dependent enhancement risks in some experimental therapies
06

Interacting drugs

Enfuvirtide (fusion inhibitor)

1 more in the full profile.

07

Biomarkers

Sensitivity to broadly neutralizing antibodies (bNAbs)Presence of specific envelope protein mutations linked to drug resistance

Beyond the preview

Go deeper on Envelope glycoprotein trimer of HIV-1 (HIV-1 Env trimer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope glycoprotein trimer of HIV-1 (HIV-1 Env trimer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call